International Stem Cell (ISCO) Capital Expenditures (2010 - 2025)
International Stem Cell's Capital Expenditures came in at $3,000 for Q4 2025, up 200.0% from $1,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
International Stem Cell (ISCO) Capital Expenditures (2010 - 2025) Analysis & Trends
For FY2025, International Stem Cell's Capital Expenditures was $43,000, down 74.1% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of 9.0% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $166,000 in FY2024 (+107.5%), $80,000 in FY2023, $1,000 in FY2022 (-95.7%) and $23,000 in FY2021 (-17.9%).
- The five-year range for quarterly Capital Expenditures is $1,000 (Q4 2024) to $120,000 (Q2 2024).
- Year-over-year, Capital Expenditures increased in three of the last seven quarters, with growth averaging 35.7%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q4 2025 (growth of 200.0%), and the weakest in Q3 2025 (a decline of 91.9%).
- Business Quant data shows ISCO's Capital Expenditures at $3,000 (Q3 2025), $32,000 (Q2 2025) and $5,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.84 Bn | 1,106.42 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 618.03 Bn | 536.55 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 507.69 Bn | 480.80 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 366.91 Bn | 321.28 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.54 Bn | 262.53 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 263.16 Bn | 236.84 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 236.31 Bn | 191.71 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 192.91 Bn | 167.11 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 171.40 Bn | 118.04 Bn | 10.94 Bn | 533.00 Mn |
| 10 | International Stem Cell | 2.16 Mn | -1.81 Mn | 1.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Jun 30, 2023 | 51,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Dec 31, 2020 | 4,000.00 |
| Sep 30, 2020 | 2,000.00 |
| Jun 30, 2020 | 19,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Dec 31, 2019 | 18,000.00 |
| Sep 30, 2019 | 33,000.00 |
| Jun 30, 2019 | 55,000.00 |
| Mar 31, 2019 | 58,000.00 |
API Access
International Stem Cell Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();